Jeffs Roger's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Mar 15, 2024
- Accession no.
- 0000950170-24-032432
- Filed
- Mar 15, 2024
- Trade date
- Mar 14-15, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.26M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jeffs RogerCIK 0001231615 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | Common Stock | MOption exerciseAcquired | +13,000 | $22.03 | +$286,390 | 133,756 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −13,000 | $69.70 | −$906,100 | 120,756 | Direct | |
| Mar 14, 2024 | Common Stock | MOption exerciseAcquired | +16,976 | $25.53 | +$433,397.28 | 137,732 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −16,976 | $69.70 | −$1,183,227.2 | 120,756 | Direct | |
| Mar 15, 2024 | Common Stock | MOption exerciseAcquired | +2,347 | $29.91 | +$70,198.77 | 123,103 | Direct | |
| Mar 15, 2024 | Common Stock | SSaleDisposed | −2,347 | $71.61 | −$168,068.67 | 120,756 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | Common Stock | MOption exerciseDisposed | −13,000 | $0.00 | $0 | 0 | Direct | |
| Mar 14, 2024 | Common Stock | MOption exerciseDisposed | −16,976 | $0.00 | $0 | 0 | Direct | |
| Mar 15, 2024 | Common Stock | MOption exerciseDisposed | −2,347 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.